Steve Taub ValueAct Surges as the Hedge Fund Benefits From Fox Battle The activist hedge fund firm has seen big gains from its positions in 21st Century Fox and Valeant Pharmaceuticals. Steve Taub July 12, 2018 Twenty-First Century Fox headquarters, New York (Alexander F. Yuan/Bloomberg)